Efficacy and safety study of Entecavir and Telbivudine in patients with chronic Hepatitis-B over 5 years

Trial Profile

Efficacy and safety study of Entecavir and Telbivudine in patients with chronic Hepatitis-B over 5 years

Completed
Phase of Trial: Phase II

Latest Information Update: 10 May 2016

At a glance

  • Drugs Entecavir (Primary) ; Telbivudine (Primary)
  • Indications Hepatitis B
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 May 2016 New trial record
    • 17 Apr 2016 Results of 5 year outcome study presented at The International Liver Congress™ 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top